Nuzenio

Moomoo Urogen Pharma

Moomoo Urogen Pharma entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 03:51:49 GMTOppenheimer Adjusts PT on UroGen Pharma to $60 From $50, Maintains Outperform Rating - Moomoo
Fri, 07 Aug 2026 03:12:57 GMTOppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $60 - Moomoo
Thu, 06 Aug 2026 19:36:04 GMTA Quick Look at Today's Ratings for UroGen Pharma Ltd(URGN.US), With a Forecast Between $48 to $75 - Moomoo
Thu, 06 Aug 2026 07:52:45 GMTTD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $60 - Moomoo
Wed, 05 Aug 2026 16:22:16 GMTUroGen Pharma 2Q Loss $14.4M >URGN - Moomoo
Wed, 05 Aug 2026 15:18:36 GMTUroGen Pharma Q2 Net Loss Narrows, Revenue Rises - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Moomoo Urogen Pharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.